Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3046|19|6|645-651

ISSN： 1397-3142

Source： PEDIATRIC TRANSPLANTATION, Vol.19, Iss.6, 2015-09, pp. : 645-651

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation

By  

Transfusion Medicine and Hemotherapy, Vol. 43, Iss. 1, 2016-0 ,pp. : 3-12

Karger

Access to resources Recommend Favorite

Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation

By  

Case Reports in Oncology, Vol. 5, Iss. 1, 2012-02 ,pp. : 110-113

Karger

Access to resources Recommend Favorite

Importance of Parenteral Nutrition in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

By  

Oncology Research and Treatment, Vol. 34, Iss. 4, 2011-03 ,pp. : 210-212

Karger

Access to resources Recommend Favorite

Allogeneic hematopoietic stem cell transplantation in pediatric myelodysplastic syndromes: A multicenter experience from Argentina

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 1, 2015-01 ,pp. : 153-157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Allogeneic Hematopoietic Stem Cell Transplantation in Mantle Cell Lymphoma: A Retrospective Analysis of 7 Patients

By  

Oncology, Vol. 89, Iss. 2, 2015-04 ,pp. : 118-123

Karger

Access to resources Recommend Favorite